CompaniesByCap
EXEL
Exelixis Inc. (EXEL)
NASDAQ · Healthcare

Exelixis Inc. Revenue 2009–2026

Exelixis Inc. annual/quarterly revenue history and growth rate from 2009 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.

  • Exelixis Inc. revenue for the quarter ending April 3, 2026 was 610.8 M, a 9.97% increase year-over-year.
  • Exelixis Inc. revenue for the twelve months ending April 3, 2026 was 2.3 B, a 12.46% increase year-over-year.
  • Exelixis Inc. annual revenue for 2026 was 2.3 B, a 6.98% increase from 2025.
  • Exelixis Inc. annual revenue for 2025 was 2.2 B, a 18.49% increase from 2023.
  • Exelixis Inc. annual revenue for 2023 was 1.8 B, a 13.60% increase from 2022.
  • Exelixis Inc. annual revenue for 2022 was 1.6 B.
Revenue
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %

Exelixis Inc. (EXEL) — Frequently Asked Questions

Exelixis Inc. (EXEL) is a publicly traded US company. It has a market capitalization of $14.82B. In fiscal 2026 it reported revenue of $2.32B and net income of $783M. Explore EXEL's stock price, financial statements, earnings history, margins and key ratios below.

What is Exelixis Inc.'s market cap?

Exelixis Inc. (EXEL) has a market capitalization of $14.82B.

What is the EXEL stock price?

EXEL trades at $52.58 (-0.77% on the day).

How much revenue does Exelixis Inc. make?

Exelixis Inc. reported revenue of $2.32B in fiscal 2026.

Is EXEL profitable?

In fiscal 2026, Exelixis Inc. reported net income of $783M.